Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD20-targeted CAR-T in B Cell Malignancies
NCT02710149Phase 2Unknown
- Sponsor
- Southwest Health System
- Start
- Mar 2016
- Primary completion
- Mar 2020
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of anti-CD20-CAR-transduced T cells in B-cell leukemia (BCL), B cell lymphoma, sponsored by Southwest Health System. Status: unknown.
02
Drugs
anti-CD20-CAR-transduced T cells
03
Conditions
B-cell leukemia (BCL)B cell lymphoma
Beyond the preview
Go deeper on NCT02710149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02710149.